Verrica’s Molluscum Treatment Rejected by FDA Following CMO Facility Deficiencies September 23, 2021 Auto Bot News 0 Verrica Pharmaceuticals receives CRL from FDA identifying deficiencies at a facility of a CMO for its NDA for VP-102.
